```html

Kevin’s Sign (Hyperpigmentation)

What is Kevin's sign (hyperpigmentation)?

Kevin’s sign refers to a distinctive pattern of increased skin pigmentation that appears as a well‑defined, often linear or triangular, darker patch on the skin. The term was first introduced in dermatology literature to describe a hyperpigmented mark that commonly develops on the inner aspect of the thigh or lower abdomen following a minor injury, friction, or inflammation. While the exact etymology of “Kevin’s sign” is anecdotal, clinicians use it as a visual cue that a localized hyperpigmentation may be a reaction to an underlying process rather than a primary pigment‑cell disorder.

Hyperpigmentation itself is the result of excess melanin production or accumulation in the epidermis or dermis. Kevin’s sign is therefore a secondary hyperpigmentation—meaning it occurs secondary to another event or condition (e.g., inflammation, trauma, medication). Recognizing this sign can help health‑care providers narrow the differential diagnosis and plan appropriate investigations.

Common Causes

Because Kevin’s sign is a reaction pattern, a wide range of conditions can trigger it. Below are the most frequently reported causes (ordered roughly from most to least common):

• Post‑inflammatory hyperpigmentation (PIH): After cuts, burns, or scratching, melanocytes become hyperactive.
• Friction or pressure dermatitis: Tight clothing, belts, or repetitive rubbing can lead to localized pigment changes.
• Medication‑induced hyperpigmentation: Drugs such as doxycycline, minocycline, amiodarone, antimalarials, and some chemotherapeutic agents.
• Hormonal changes: Pregnancy (melasma) or endocrine disorders (e.g., Cushing’s syndrome) may accentuate pigment response to minor trauma.
• Fungal infections: Tinea versicolor or chronic cutaneous candidiasis can leave hyperpigmented macules that mimic Kevin’s sign.
• Autoimmune skin disease: Lupus erythematosus or dermatomyositis sometimes produce “cutaneous lupus” patches that darken after inflammation.
• Metabolic disorders: Addison’s disease (primary adrenal insufficiency) leads to diffuse hyperpigmentation that may become focal after injury.
• Rare genetic conditions: E.g., Peutz‑Jeghers syndrome presents with mucocutaneous pigmented spots, occasionally accentuated by trauma.
• Skin cancer precursors: Early lentigo maligna or actinic keratosis can appear as hyperpigmented macules that darken after sun exposure.
• Contact allergens: Nickel, fragrances, or dyes that cause a localized allergic dermatitis may evolve into a pigmented patch.

Associated Symptoms

Kevin’s sign rarely exists in isolation. The following symptoms often accompany the hyperpigmented patch, depending on the underlying cause:

• itching (pruritus) or burning sensation
• mild to moderate pain, especially if the lesion follows a recent abrasion or burn
• slight swelling or erythema that resolves before the pigment darkens
• scaling or flaking skin (common with fungal infections or eczema)
• visible skin texture changes (e.g., a raised border in actinic keratosis)
• systemic signs such as fatigue, weight loss, or hyperpigmented mucous membranes in endocrine disorders

When to See a Doctor

Most cases of Kevin’s sign are benign and improve with time or simple skin care. However, you should seek professional evaluation if you notice any of the following warning signs:

• The pigmented area expands rapidly or becomes irregular in shape.
• Bleeding, ulceration, or crusting occurs.
• Persistent pain, throbbing, or a sensation of “heat” that does not subside.
• Accompanying systemic symptoms (fever, night sweats, unexplained weight loss).
• Inability to attribute the pigment change to a clear trigger (e.g., no recent injury or medication).
• History of skin cancer or a strong family history of melanoma.

Diagnosis

Evaluation typically follows a stepwise approach:

1. Clinical history – Detailed questioning about recent injuries, new medications, sun exposure, and systemic illnesses.
2. Physical examination – Inspection of the lesion’s size, shape, borders, and texture. Dermoscopy may be used to assess pigment patterns.
3. Wood’s lamp examination – Helps differentiate melanin‑based pigmentation from fungal or bacterial infections (fluorescent changes).
4. Skin scraping or biopsy – If infection, autoimmune disease, or malignancy is suspected, a sample is taken for histopathology and culture.
5. Laboratory tests – When systemic causes are considered, blood work (e.g., cortisol, ACTH, thyroid panel, complete blood count) may be ordered.

Most dermatologists will first rule out dangerous conditions (melanoma, basal cell carcinoma) before attributing the sign to a benign cause.

Treatment Options

Management depends on the root cause. Below are the main therapeutic categories:

1. Topical agents

• Hydroquinone 4% or 2% (over‑the‑counter): Inhibits melanin synthesis; used for PIH.
• Azelaic acid 15–20%: Anti‑inflammatory and depigmenting; useful for acne‑related PIH.
• Retinoids (tretinoin, adapalene): Promote epidermal turnover, fading hyperpigmentation over weeks to months.
• Vitamin C serums: Antioxidant that can lighten melanin over time.

2. Oral medications

• Tranexamic acid: Occasionally prescribed for stubborn melasma‑type PIH.
• Systemic antifungals (e.g., terbinafine): If a fungal infection underlies the pigment change.
• Hormonal therapy: In cases linked to estrogen or progesterone fluctuations (consult an endocrinologist).

3. Procedural interventions

• Chemical peels (glycolic or TCA): Remove superficial pigmented layers.
• Microdermabrasion or laser therapy (Q‑switched Nd:YAG, fractional lasers): Target deeper melanin deposits.
• Phototherapy (narrow‑band UVB): Occasionally used for inflammatory skin disorders that cause PIH.

4. General skin‑care measures

• Gentle cleansing with non‑scratching soaps.
• Moisturizing with barrier‑repair creams (ceramides, hyaluronic acid).
• Avoiding further friction or trauma to the area.
• Broad‑spectrum sunscreen (SPF 30 or higher) applied daily—critical to prevent darkening.

Prevention Tips

While not all cases of Kevin’s sign can be avoided, many triggers are modifiable:

• Protect skin from friction: Wear loose‑fitting clothing, especially during prolonged sitting or exercise.
• Use protective barriers: Silicone pads or moleskin over areas prone to rubbing.
• Prompt wound care: Clean cuts or abrasions promptly and keep them covered to reduce inflammation.
• Sun protection: Sunscreen, hats, and shade reduce melanin over‑production after injury.
• Medication review: Discuss any new drugs with your prescriber if you notice skin darkening.
• Maintain skin hygiene: Treat fungal infections early; keep feet and groin dry.
• Regular skin checks: Self‑examination every month helps spot new or changing lesions early.

Emergency Warning Signs

If any of the following occur, seek immediate medical attention (e.g., urgent care, emergency department):

• Sudden, severe pain or throbbing in the pigmented area.
• Rapid expansion of the lesion accompanied by swelling or fever.
• Bleeding, oozing, or an ulcer that does not heal within 2 weeks.
• Signs of systemic infection such as chills, high fever (>38.5 °C / 101 °F), or malaise.
• Neurological symptoms (numbness, weakness) near the spot – could indicate deeper tissue involvement.

---

**References**

• Mayo Clinic. “Post‑inflammatory hyperpigmentation.” https://www.mayoclinic.org/
• American Academy of Dermatology. “Hyperpigmentation: Causes, treatment, and prevention.”
• National Institutes of Health (NIH). “Skin pigmentation disorders.” https://www.nih.gov/
• Cleveland Clinic. “How to treat hyperpigmentation.”
• World Health Organization. “Guidelines on skin health and infection control.”

```